Immunomodulators are becoming a viableadjunct to established modalitie translation - Immunomodulators are becoming a viableadjunct to established modalitie Indonesian how to say

Immunomodulators are becoming a via

Immunomodulators are becoming a viable
adjunct to established modalities offering a novel approach for the treatment of infectious disease in the coming decades of 21st
century
0/5000
From: -
To: -
Results (Indonesian) 1: [Copy]
Copied!
Immunomodulators menjadi layaktambahan untuk mendirikan modalitas menawarkan pendekatan baru untuk pengobatan penyakit menular pada dekade mendatang 21abad
Being translated, please wait..
Results (Indonesian) 2:[Copy]
Copied!
Imunomodulator yang menjadi layak
tambahan untuk modalitas didirikan menawarkan pendekatan baru untuk pengobatan penyakit menular dalam beberapa dekade mendatang dari 21
abad
Being translated, please wait..
 
Other languages
The translation tool support: Afrikaans, Albanian, Amharic, Arabic, Armenian, Azerbaijani, Basque, Belarusian, Bengali, Bosnian, Bulgarian, Catalan, Cebuano, Chichewa, Chinese, Chinese Traditional, Corsican, Croatian, Czech, Danish, Detect language, Dutch, English, Esperanto, Estonian, Filipino, Finnish, French, Frisian, Galician, Georgian, German, Greek, Gujarati, Haitian Creole, Hausa, Hawaiian, Hebrew, Hindi, Hmong, Hungarian, Icelandic, Igbo, Indonesian, Irish, Italian, Japanese, Javanese, Kannada, Kazakh, Khmer, Kinyarwanda, Klingon, Korean, Kurdish (Kurmanji), Kyrgyz, Lao, Latin, Latvian, Lithuanian, Luxembourgish, Macedonian, Malagasy, Malay, Malayalam, Maltese, Maori, Marathi, Mongolian, Myanmar (Burmese), Nepali, Norwegian, Odia (Oriya), Pashto, Persian, Polish, Portuguese, Punjabi, Romanian, Russian, Samoan, Scots Gaelic, Serbian, Sesotho, Shona, Sindhi, Sinhala, Slovak, Slovenian, Somali, Spanish, Sundanese, Swahili, Swedish, Tajik, Tamil, Tatar, Telugu, Thai, Turkish, Turkmen, Ukrainian, Urdu, Uyghur, Uzbek, Vietnamese, Welsh, Xhosa, Yiddish, Yoruba, Zulu, Language translation.

Copyright ©2025 I Love Translation. All reserved.

E-mail: